Chronic Pain News and Research

RSS

Young people with serious genetic blood disorder are not getting right help at school

A new study suggests young people with a serious genetic blood disorder are not getting the right help at school, especially pupils who miss lessons due to sickness.

20 Jul 2011

Convergence initiates CNV1014802 Phase II study in lumbosacral radiculopathy

Convergence Pharmaceuticals Limited, the company focused on the development of novel and high value analgesic medicines, today announces that the Phase II proof of concept study with CNV1014802 for treating pain associated with lumbosacral radiculopathy (LSR) has started.

19 Jul 2011

Chronic self-reported NSAID use associated with increased risk of adverse events in hypertensive patients with CAD

A study published in the July issue of The American Journal of Medicine, reports that among hypertensive patients with coronary artery disease, chronic self-reported use of non-steroidal anti-inflammatory drugs (NSAIDs) was associated with an increased risk of adverse events during long-term follow-up. Long-term NSAID use is common for treatment of chronic pain.

13 Jul 2011

FDA clears St. Jude Medical's Epiducer lead delivery system for neurostimulation

St. Jude Medical, Inc., a global medical device company, today announced the U.S. Food and Drug Administration (FDA) clearance and limited market release of the Epiducer lead delivery system for neurostimulation therapy.

13 Jul 2011

New genetic clues about ankylosing spondylitis

A study involving over 5,000 people living with the joint disorder ankylosing spondylitis has identified a series of genetic variants associated with increased susceptibility to the condition as well as providing new clues to how the condition may be treated in the future.

11 Jul 2011

Researchers find new molecule that controls pain sensitivity from UVB irradiation

Researchers at King's College London have found a molecule in the body which controls sensitivity to pain from UVB irradiation, identifying it as a new target for medicines to treat pain caused by other common inflammatory conditions such as arthritis.

7 Jul 2011

IOM report highlights need for changes in pain management

Defining pain as "a major public health problem," the Institute of Medicine offered recommendations to make systemic and cultural changes in how pain could either be prevented or managed better.

1 Jul 2011

IOM report can set the stage for improvements in pain care, says APS

The American Pain Society (APS) said that "Relieving Pain in America: A Blueprint for Transforming Prevention, Treatment, and Research, the report submitted to Congress today by the Institute of Medicine, is a major step forward in addressing the nation's leading public health problem - untreated and undertreated chronic pain.

30 Jun 2011

100 million Americans suffer pain - many in silence

According to a report released by the Institute of Medicine Wednesday, nearly a third of Americans experience long-lasting pain and too often feel stigma rather than relief from a health care system poorly prepared to treat them. Chronic pain is costing the nation at least $558 billion a year in medical bills, sick days and lost productivity, the report found. That's more than the cost of heart disease, the top killer.

30 Jun 2011

Cipher grants Vertical exclusive U.S. distribution rights to CIP-TRAMADOL ER

Cipher Pharmaceuticals Inc. today announced that it has entered into a definitive distribution and supply agreement with Vertical Pharmaceuticals, Inc., a U.S.-based specialty pharmaceutical company, under which Cipher has granted Vertical the exclusive right to market, sell and distribute CIP-TRAMADOL ER in the United States.

29 Jun 2011

Bio-Nucleonics' generic Metastron, an option for metastatic cancer bone pain therapy

Bio-Nucleonics' lead product Strontium Chloride Sr-89 Injection USP (Strontium-89), which is the generic version of Metastron®, is an option to consider for metastatic cancer bone pain therapy, typically caused by advanced stage breast, prostate or lung cancer.

28 Jun 2011

Health law headlines: PR challenges and overhaul tell-alls

Although Democrats are having some success with attacks on the GOP Medicare plan, they are still playing defense on the health law, according to Politico. Meanwhile, former Office of Management and Budget Director Peter Orszag writes a "tell-all" for the magazine Foreign Affairs about the health overhaul.

28 Jun 2011

First Edition: June 27, 2011

Today's headlines include reports about the status of ongoing deficit negotiations and details about a "stealth" survey on access to doctors.

27 Jun 2011

Millennium Labs founder receives Ernst & Young award in Life Sciences category

Millennium Laboratories, a leading provider of medication monitoring services to physicians and staff treating chronic pain, announced today that James Slattery, CEO and founder, has received the Ernst & Young Entrepreneur of the Year 2011 San Diego Award in the Life Sciences category.

21 Jun 2011

Tulane University, VA grant IRB approval for new TIGR Matrix clinical trial in hernia repair

Novus Scientific today announced that Tulane University School of Medicine and Department of Veterans Affairs have granted IRB approval to a new trial: A Study Evaluating Efficacy of TIGR® Matrix Surgical Mesh used in Elective Open Inguinal Hernia Repair.

16 Jun 2011

UCLA's new center to explore links between brain, digestive system in chronic disorders

Investigators at UCLA's Center for Neurobiology of Stress have been studying the links between the brain and digestive system in the development and treatment of common chronic digestive disorders in adults and children.

16 Jun 2011

Train the brain to manage chronic pain

How do you function when chronic pain is a part of your daily life? The UC San Diego Center for Mindfulness (UCSD CFM) at UC San Diego Health System offers a novel program to help people who are dealing with chronic pain "train their brains" to lessen their experience of discomfort and, in some cases, eliminate it.

16 Jun 2011

Spinal Modulation completes Series D financing for $30 million

Spinal Modulation, Inc. announced today the completion of its $30 million Series D financing. Medtronic, Inc. joined existing investors DeNovo Ventures, ePlanet/DFJ, InCube Ventures, Johnson & Johnson Development Corporation (JJDC), Kleiner Perkins Caufield & Byers, MedVenture Associates, and Raffles Venture Partners.

15 Jun 2011

Risky behavior, psychiatric disorders and substance abuse contribute to opioid overdose

Deaths related to prescription opioid therapy are under intense scrutiny, prompting those in pain medicine-clinicians, patient advocates, and regulators-to understand the causes behind avoidable mortality in legitimately treated patients.

13 Jun 2011

Ameritox launches Rx Guardian CD, next-generation pain-medication monitoring solution

Ameritox, the leader in pain-medication monitoring, today announced the launch of Rx Guardian CD, its next-generation pain-medication monitoring solution and part of the patented Rx Guardian process.

9 Jun 2011

Chronic Pain News and Research

Young people with serious genetic blood disorder are not getting right help at school

Convergence initiates CNV1014802 Phase II study in lumbosacral radiculopathy

Chronic self-reported NSAID use associated with increased risk of adverse events in hypertensive patients with CAD

FDA clears St. Jude Medical's Epiducer lead delivery system for neurostimulation

New genetic clues about ankylosing spondylitis

Researchers find new molecule that controls pain sensitivity from UVB irradiation

IOM report highlights need for changes in pain management

IOM report can set the stage for improvements in pain care, says APS

100 million Americans suffer pain - many in silence

Cipher grants Vertical exclusive U.S. distribution rights to CIP-TRAMADOL ER

Bio-Nucleonics' generic Metastron, an option for metastatic cancer bone pain therapy

Health law headlines: PR challenges and overhaul tell-alls

First Edition: June 27, 2011

Millennium Labs founder receives Ernst & Young award in Life Sciences category

Tulane University, VA grant IRB approval for new TIGR Matrix clinical trial in hernia repair

UCLA's new center to explore links between brain, digestive system in chronic disorders

Train the brain to manage chronic pain

Spinal Modulation completes Series D financing for $30 million

Risky behavior, psychiatric disorders and substance abuse contribute to opioid overdose

Ameritox launches Rx Guardian CD, next-generation pain-medication monitoring solution

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News